Skip to content
value.today

Weed Inc.

BUDZ
$9 Mlast known market cap, Jul 2023 — no current value
Compare
World rank
—
no current market cap
Revenue
—
For year ending December-2025
Net income
$-1 M
SEC filing
Employees
—

Weed Inc. in brief

Weed Inc. is a listed company in the Pharmaceutical industry, based in Tucson, Arizona, USA. Its last known market value was $9 M (July 2023); there is no current figure.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Weed Inc.

We were originally incorporated under the name Plae, Inc., in the State of Arizona on August 20, 1999. At the time we operated under the name Plae, Inc., no business was conducted. No books or records were maintained and no meetings were held. In essence, nothing was done after incorporation until Glenn E. Martin took possession of Plae, Inc. in January 2005. On February 18, 2005, the corporate name was changed to King Mines, Inc. and then subsequently changed to its current name, United Mines, Inc., on March 30, 2005. No shares were issued until the Company became United Mines, Inc. From 2005 until 2015, we were an exploration stage mineral exploration company that owned a number of unpatented BLM mining claims and Arizona State Land Department exploration leases.

From the company's annual report filed with the US SEC: read the report

Weed Inc. timeline

2 events, 2007–2014
  1. 2007
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  3. 2014
  4. ✎
    Renamed Weed, Inc.
    Formerly United Mines Inc.

Events of Weed Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$8 M$17 M$25 M$33 M2023

World rank over time

▼ down 2,795 places since 2022
2022-01-07: #29153#29,15320222023-07-30: #31948#31,9482023

Rank in USA: #5,158 (Jan 2022) · #5,458 (Jul 2023)

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2018: revenue —, net income $-29M—FY18Fiscal year ending Dec 2019: revenue —, net income $-28M—FY19Fiscal year ending Dec 2020: revenue —, net income $-4M—FY20Fiscal year ending Dec 2021: revenue —, net income $-3M—FY21Fiscal year ending Dec 2022: revenue —, net income $-2M—FY22Fiscal year ending Dec 2023: revenue —, net income $-0M—FY23Fiscal year ending Dec 2024: revenue —, net income $-1M—FY24Fiscal year ending Dec 2025: revenue —, net income $-1M—FY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025——$-1M$-1M—
Dec 2024——$-1M$-1M—
Dec 2023——$-1M$-0M—
Dec 2022——$-2M$-2M—
Dec 2021——$-3M$-3M—
Dec 2020——$-4M$-4M—
Dec 2019——$-27M$-28M—
Dec 2018——$-28M$-29M—

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$-0M——$-0.01—
Dec 2024$-0M——$-0.00—
Dec 2023$-1M$0M$-1M$-0.00—
Dec 2022$-1M$0M$-1M——
Dec 2021$-1M$0M$-1M$-0.02—
Dec 2020$-0M$0M$-0M$-0.04—
Dec 2019$-1M$0M$-1M$-0.26—
Dec 2018$-3M$1M$-4M$-0.28—

Quarterly results

USD · three months to · source: SEC filings
RevenueNet income
Three months to Sep 2024: revenue —, net income $-0M—Sep ’24Three months to Dec 2024: revenue —, net income $-0M—Dec ’24Three months to Mar 2025: revenue —, net income $-0M—Mar ’25Three months to Jun 2025: revenue —, net income $-0M—Jun ’25Three months to Sep 2025: revenue —, net income $-0M—Sep ’25Three months to Dec 2025 (from the annual report): revenue —, net income $-1M—Dec ’25Three months to Mar 2026: revenue —, net income $-0M—Mar ’26Three months to Jun 2026: revenue —, net income $-0M—Jun ’26

Latest quarter to Jun 2026: revenue —, net income $-0M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.

SEC filings

Official filings of Weed Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
—
Operating income
$-1 M
Net income
$-1 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$1 M
Total liabilities
$1 M
Total equity
$-1 M

As of December-2025

Insider trading at Weed Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$0
0 purchases, 0 insiders
Sold, 12 months
$40 K
16 sales, 1 insider
Net, 12 months
-$40 K
open market only
Insiders on file
8
since
-$25 K$0Jan 2026: bought $0 (0 trades), sold $2 K (1 trades)Jan 26Feb 2026: bought $0 (0 trades), sold $7 K (5 trades)FebMay 2026: bought $0 (0 trades), sold $3 K (3 trades)MayAug 2026: bought $0 (0 trades), sold $25 K (4 trades)AugSep 2026: bought $0 (0 trades), sold $4 K (3 trades)Sep
Bought (open market)Sold (open market)Hover a month for the totals
Weed Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Nicole M. BreenSecretary and Treasurer, Director, 10% ownerSellindirect-60,000$0.030$2 K29.75 MForm 4
filed Nicole M. BreenSecretary and Treasurer, Director, 10% ownerSellindirect-10,000$0.030$30029.81 MForm 4
filed Nicole M. BreenSecretary and Treasurer, Director, 10% ownerSellindirect-50,000$0.030$2 K29.82 MForm 4
filed Nicole M. BreenSecretary and Treasurer, Director, 10% ownerSellindirect-50,000$0.030$2 K29.87 MForm 4
filed Nicole M. BreenSecretary and Treasurer, Director, 10% ownerSellindirect-80,000$0.250$20 K29.92 MForm 4
filed Nicole M. BreenSecretary and Treasurer, Director, 10% ownerSellindirect-50,000$0.030$2 K30.00 MForm 4
filed Nicole M. BreenSecretary and Treasurer, Director, 10% ownerSellindirect-50,000$0.030$2 K30.05 MForm 4
filed Nicole M. BreenSecretary and Treasurer, Director, 10% ownerSellindirect-5,008$0.040$20030.10 MForm 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Weed Inc. scorecard#

Passes 1 of the 7 checks that could be worked out. Fiscal year 2025.

  • Valuationnot known
    • –P/E below its peers' medianNo market cap.
    • –Price to book below its peers' medianNo market cap.
    • –Price to sales below its peers' medianNo market cap.
    • –Free cash flow yield above 5%No market cap.
    • –Earnings yield above the 10-year Treasury yieldNo market cap.
    • –The price assumes slower growth than the last three years'No market cap.
  • Growth1 of 2
    • –Revenue grew in the newest yearRevenue of the year before is not on file.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • ✗Earnings per share grew in the newest year-0.01 vs -0.00Diluted EPS -0.01 in fiscal 2025 against -0.00 the year before (report's currency).
    • ✓Net income higher than five years earlier-$1 M-$1 M in fiscal 2025 against -$4 M in 2020.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability0 of 2
    • ✗Profitable in the newest year-$1 MNet income -$1 M in fiscal 2025.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
    • –Operating margin above its peers' medianNo operating margin on file.
    • –Return on equity above 15%No return on equity (equity missing or negative).
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health0 of 2
    • ✗Short-term assets cover short-term liabilities0.0×Current ratio 0.04 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year9.5%Diluted shares up 9.5% in fiscal 2025.
    • –Dividends and buybacks above 3% of the market valueNo market cap.
    • –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.

Worked out from the statements as filed (sec), the medians of Pharmaceutical, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Weed Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD thousands; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Weed Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019FY 2018to Dec 31, 2018FY 2017to Dec 31, 2017FY 2011to Dec 31, 2011
Income statement
Revenue0000—00000
Cost of revenue0000——————
Gross profit0000——————
Selling and marketing—————————13
General and administrative1,1283513955677983149701,358r6722,043
Operating expenses1,3285307711,5052,8014,07627,41728,406r2,3842,087
Operating income−1,328−530−771−1,505−2,801−4,076−27,417−28,406r−2,3842,087
Interest expense and finance costs—5.145r1173941121214−3.5
Other non-operating income (expense)−44−50740−23−4011−113−909r−1,0983.5
Income before tax−1,372−510—−1,528−2,842−4,065————
Income tax0.00.41.00——————
Net income including minority interests—−511−32−1,528——————
Net income attributable to shareholders−1,372−511−32−1,528−2,842−4,065−27,530−29,315−3,4822,090
Earnings per share, basic—-0.00-0.00-0.01-0.02-0.04-0.26r-0.28-0.03-0.17
Earnings per share, diluted-0.01-0.00-0.00—-0.02-0.04-0.26r-0.28-0.03-0.17
Shares, weighted average (basic)—124124122117—————
Shares, weighted average (diluted)136124124—11711210810310112
Balance sheet
Cash and cash equivalents3315929031620132.5711610.0
Receivables————0.80.80.80.00—
Other current assets3.94.14.91.60.8—————
Current assets48190320342422551264921943.4
Property, plant and equipment4764965161,2091,8771,5211,7802,481r1,00017
Right-of-use (leased) assets4.8193244——————
Goodwill——000—————
Other intangible assets3134——414346490—
Total assets5607389041,6341,9591,8191,9533,0211,308132
Accounts payable18016818419024624221224022963
Current liabilities1,2489596491,4641,342937753259948243
Total liabilities1,2489596491,4641,342937753259948243
Retained earnings−86,275−84,903−84,393−84,361−82,833−79,991−75,926−48,396−19,081−7,181
Shareholders' equity−688−2212551706188821,2002,762360−111
Total liabilities and equity5607389041,6341,9591,8191,9533,0211,308132
Shares outstanding147125123123119r11310910610114
Cash-flow statement
Depreciation and amortization222352111130146159181451.8
Share-based compensation80020——2,0032,01622,77121,20101,877
Cash from operating activities−195−416−1,074−813−569−431−1,111−3,181−670−124
Capital expenditure——−100−2710−3.0−826−5350
Intangible assets bought—————00−5000
Cash from investing activities——1,6311,257−271164−3.0−876−5350
Shares issued——040—————110
Cash from financing activities70285−588−1498492771,0463,9671,366123
Exchange-rate effect on cash−1.2−0.8——−1.40.5−0.6———
Change in cash—−130−312958.59.6−67−91161−1.1
Report10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Jun 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Events at Weed Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Directors and officers 1 · Material agreement 4 · Unregistered share sale 1

Weed Inc.: events reported to the SEC
FiledWhat happenedFiling
Material agreementUnregistered share sale8-K
Material agreement8-K
Material agreement8-K
Material agreement8-K
Directors and officers8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Aug 4, 2022

Acquisitions and funding#

Private share sales · funding history

Private share sales of Weed Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2018$12 MPrivate placement after listing$10 to $50 million2equitySEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
Weed Inc.🇺🇸$9 M———
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jul 30, 2023 (last known)
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Profile updated:
Nov 16, 2026

Figures from SEC filing, value.today research, SEC annual report; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Weed Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Weed Inc.'s ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Weed Inc.? Suggest a correction